Cargando…

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study

OBJECTIVE: To evaluate temporal trends in neoadjuvant chemotherapy (NAC) utilisation and outcomes in patients with locally advanced upper tract urothelial carcinoma (UTUC). PATIENTS AND METHODS: We included 289 patients from seven hospitals who underwent radical nephroureterectomy (RNU) for locally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamaya, Tomoko, Hatakeyama, Shingo, Tanaka, Toshikazu, Kubota, Yuka, Togashi, Kyo, Hosogoe, Shogo, Fujita, Naoki, Kusaka, Ayumu, Tokui, Noriko, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518523/ https://www.ncbi.nlm.nih.gov/pubmed/33484231 http://dx.doi.org/10.1111/bju.15346

Ejemplares similares

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)
por: Momota, Masaki, et al.
Publicado: (2020)

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study
por: Ozaki, Yusuke, et al.
Publicado: (2023)

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
por: Ozaki, Kai, et al.
Publicado: (2021)

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
por: Miura, Yuki, et al.
Publicado: (2021)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
por: Okuyama, Yoshiharu, et al.
Publicado: (2021)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Renal metastasis of ovarian granulosa cell tumor
por: Togashi, Kyo, et al.
Publicado: (2022)

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)
por: Iwamura, Hiromichi, et al.
Publicado: (2021)

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study
por: Kubota, Yuka, et al.
Publicado: (2017)

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma
por: Hosogoe, Shogo, et al.
Publicado: (2017)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient
por: Narita, Takuya, et al.
Publicado: (2014)

A Case of Malignant Pheochromocytoma Detected during Fertility Treatment
por: Hagiwara, Kazuhisa, et al.
Publicado: (2014)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Kodama, Hirotake, et al.
Publicado: (2021)

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
por: Kusaka, Ayumu, et al.
Publicado: (2017)

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
por: Hamano, Itsuto, et al.
Publicado: (2017)

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients
por: Hamaya, Tomoko, et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
por: Hamaya, Tomoko, et al.
Publicado: (2023)

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy
por: Hosogoe, Shogo, et al.
Publicado: (2015)

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
por: Ishii, Noritaka, et al.
Publicado: (2022)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Testicular Metastasis of Prostate Cancer: A Case Report
por: Kusaka, Ayumu, et al.
Publicado: (2014)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers
por: Togashi, Kyo, et al.
Publicado: (2022)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Fujita, Naoki, et al.
Publicado: (2023)

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy
por: Iwamura, Hiromichi, et al.
Publicado: (2014)

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Momota, Masaki, et al.
Publicado: (2018)

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
por: Anan, Go, et al.
Publicado: (2017)

Recent progress and perspectives on prostate cancer biomarkers
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas
por: Tanaka, Toshikazu, et al.
Publicado: (2017)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan
por: Hatakeyama, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fj0tslp82h1l6gnlug7n57huab